Global Epilepsy Monitoring Devices Market Size (2024 - 2029)

The epilepsy monitoring devices market is anticipated to experience growth over the forecast period, driven by increasing global incidences of epilepsy and the demand for early treatment solutions. The COVID-19 pandemic has positively influenced market expansion due to heightened awareness and need for monitoring devices among at-risk populations. The aging demographic and technological advancements further contribute to market growth, despite challenges such as high equipment costs and unfavorable reimbursement policies.

Market Size of Global Epilepsy Monitoring Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Epilesy Monitoring Devices Market Overview
Study Period 2019 - 2029
Market Size (2024) USD 510.03 Million
Market Size (2029) USD 661.87 Million
CAGR (2024 - 2029) 5.35 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Global Epilepsy Monitoring Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Epilepsy Monitoring Devices Market Analysis

The Global Epilepsy Monitoring Devices Market size is estimated at USD 510.03 million in 2024, and is expected to reach USD 661.87 million by 2029, growing at a CAGR of 5.35% during the forecast period (2024-2029).

COVID-19 is expected to have a positive impact on the global demand for epilepsy monitoring devices in its latter phase since the population with epilepsy was at a higher risk of encountering fatalities. This is mainly due to the increasing incidences of seizures and epilepsy among the people who were affected by COVID-19 disease. According to the data published by the American Epilepsy Society (AES) in December 2021, patients with epilepsy were nearly 1.5 times more likely to die of COVID-19 than other infected patients. These circumstances have increased the demand for epilepsy monitoring devices to opt for treatments early on. Thus, COVID-19 is expected to have a considerable impact on the growth of the market.

Increasing incidences of epilepsy among people across the world are expected to drive the growth of the epilepsy monitoring devices market. According to the World Health Organization's February 2022 update, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. It also reported that nearly 80% of people with epilepsy live in low- and middle-income countries. The same source also reported that it is estimated that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. Therefore, the increasing incidences of epilepsy cases across the globe are expected to increase the demand for epilepsy monitoring devices as they provide critical insights into the type of seizures. Furthermore, the increase in the geriatric population vulnerable to developing epilepsy and seizures across the globe also plays a crucial role in driving the market's growth.

Additionally, the investment by the market players and advancements in technology are also propelling the growth of the market. For instance, in July 2022, Breakthrough Victoria invested in Victorian medical technology group Seer Medical to support its plan to become one of the global leaders in epilepsy home monitoring and management. The contribution will allow Seer to nearly double its workforce and footprint in Victoria while expanding into the United States and the United Kingdom.

Thus, owing to the abovementioned factors, the market is expected to project growth over the forecast period. However, the high cost of equipment and unfavorable reimbursement policies may hinder the growth of the market.

Epilepsy Monitoring Devices Industry Segmentation

As per the scope of this report, an epilepsy monitoring device is a type of electronic device that can identify seizures in epilepsy conditions. The Epilepsy Monitoring Devices market is segmented by Product (Conventional Devices and Wearable Devices), Technology (Vagus Nerve stimulation, Deep brain Stimulation, Accelorometry, Responsive neurostimulation), Detection devices (Electroencephalogram, Intracranial EEG, Surface Electromyography, Video Detection systems), End User (Hospitals and Ambulatory services, Neurology centers, Diagnostic centers) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values in USD million for the above segments.

By Product
Conventional devices
Wearable devices
By Technology
Vagus nerve stimulation
Deep brain stimulation
Accelometry
Responsive neurostimulation
By Detection
Elecetroencephalogram
Intracranial EEG
Surface Electromyography
Video Detection Systems
By End User
Hospitals and Ambulatory services
Neurology centers
Diagnostic centers
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Epilepsy Monitoring Devices Market Size Summary

The epilepsy monitoring devices market is poised for significant growth, driven by the increasing prevalence of epilepsy globally and the rising demand for early diagnosis and treatment. The market is expected to expand steadily over the forecast period, supported by advancements in technology and increased investment from key players. The COVID-19 pandemic has further accelerated demand, as individuals with epilepsy faced higher risks, prompting a greater need for monitoring devices. The market is characterized by a mix of conventional and advanced devices, with conventional electroencephalogram (EEG) devices maintaining a strong presence due to their safety and efficiency in continuous monitoring. The geriatric population's vulnerability to epilepsy also contributes to the market's expansion, as does the growing awareness and need for proper diagnosis and treatment in low- and middle-income countries.

North America is anticipated to be a major growth region, fueled by the high incidence of neurological disorders and the presence of leading market players investing in research and development. The region's market growth is further bolstered by regulatory approvals for innovative devices, such as wearable EEG systems, which enhance remote monitoring capabilities. The competitive landscape of the market is moderately concentrated, with several key players dominating the scene. Companies like Medpage Ltd, Boston Scientific Corporation, and Koninklijke Philips N.V. are at the forefront, driving innovation and expanding their product offerings. Despite challenges such as high equipment costs and unfavorable reimbursement policies, the market is expected to continue its upward trajectory, supported by ongoing technological advancements and strategic investments.

Explore More

Global Epilepsy Monitoring Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing incidence of Epilepsy

      2. 1.2.2 Rising awareness of neurodegenerative disorders, including epilepsy

    3. 1.3 Market Restraints

      1. 1.3.1 High cost of the equipment

      2. 1.3.2 Unfavourable Reimbursement policies

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - in USD million)

    1. 2.1 By Product

      1. 2.1.1 Conventional devices

      2. 2.1.2 Wearable devices

    2. 2.2 By Technology

      1. 2.2.1 Vagus nerve stimulation

      2. 2.2.2 Deep brain stimulation

      3. 2.2.3 Accelometry

      4. 2.2.4 Responsive neurostimulation

    3. 2.3 By Detection

      1. 2.3.1 Elecetroencephalogram

      2. 2.3.2 Intracranial EEG

      3. 2.3.3 Surface Electromyography

      4. 2.3.4 Video Detection Systems

    4. 2.4 By End User

      1. 2.4.1 Hospitals and Ambulatory services

      2. 2.4.2 Neurology centers

      3. 2.4.3 Diagnostic centers

    5. 2.5 Geography

      1. 2.5.1 North America

        1. 2.5.1.1 United States

        2. 2.5.1.2 Canada

        3. 2.5.1.3 Mexico

      2. 2.5.2 Europe

        1. 2.5.2.1 Germany

        2. 2.5.2.2 United Kingdom

        3. 2.5.2.3 France

        4. 2.5.2.4 Italy

        5. 2.5.2.5 Spain

        6. 2.5.2.6 Rest of Europe

      3. 2.5.3 Asia-Pacific

        1. 2.5.3.1 China

        2. 2.5.3.2 Japan

        3. 2.5.3.3 India

        4. 2.5.3.4 Australia

        5. 2.5.3.5 South Korea

        6. 2.5.3.6 Rest of Asia-Pacific

      4. 2.5.4 Middle East and Africa

        1. 2.5.4.1 GCC

        2. 2.5.4.2 South Africa

        3. 2.5.4.3 Rest of Middle East and Africa

      5. 2.5.5 South America

        1. 2.5.5.1 Brazil

        2. 2.5.5.2 Argentina

        3. 2.5.5.3 Rest of South America

Global Epilepsy Monitoring Devices Market Size FAQs

The Global Epilepsy Monitoring Devices Market size is expected to reach USD 510.03 million in 2024 and grow at a CAGR of 5.35% to reach USD 661.87 million by 2029.

In 2024, the Global Epilepsy Monitoring Devices Market size is expected to reach USD 510.03 million.

Epilepsy Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)